SKU(재고 관리 코드):ELK9554
Human LTE4(Cysteinyl Leukotrienes E4) ELISA Kit
Human LTE4(Cysteinyl Leukotrienes E4) ELISA Kit
Human LTE4(Cysteinyl Leukotrienes E4) ELISA Kit
Overview
Product name: | Human LTE4(Cysteinyl Leukotrienes E4) ELISA Kit |
Reactivity: | Human |
Alternative Names: | LTE4 ELISA Kit; Cysteinyl Leukotrienes E4 ELISA Kit |
Assay Type: | Competitive Inhibition |
Sensitivity: | 5.25 pg/mL |
Standard: | 1000 pg/mL |
Detection Range: | 15.63-1000 pg/mL |
Sample Type: | serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids |
Assay Length: | 2h |
Research Area: | Immunology; Biochemicals |
Test principle: | This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with Human LTE4 protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human LTE4. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human LTE4 in the samples is then determined by comparing the OD of the samples to the standard curve. |
Standard curve
Concentration (ng/mL) | OD | Corrected OD |
---|---|---|
1000.00 | 0.197 | — |
500.00 | 0.433 | — |
250.00 | 0.651 | — |
125.00 | 0.897 | — |
62.50 | 1.197 | — |
31.25 | 1.583 | — |
15.63 | 1.792 | — |
0.00 | 2.211 | — |
Precision
Intra-assay Precision (Precision within an assay):CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays):CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
Recovery
Matrices listed below were spiked with certain level of recombinant LTE4 and the recovery rates were calculated by comparing the measured value to the expected amount of LTE4 in samples.
Matrix | Recovery range | Average |
---|---|---|
serum(n=5) | 95-107% | 101% |
EDTA plasma(n=5) | 90-105% | 97% |
Heparin plasma(n=5) | 93-107% | 100% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of LTE4 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
---|---|---|---|---|
serum(n=5) | 87-96% | 88-101% | 82-95% | 95-104% |
EDTA plasma(n=5) | 93-105% | 82-101% | 97-106% | 85-98% |
Heparin plasma(n=5) | 81-92% | 87-97% | 95-102% | 88-97% |